Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes
Monika Sarkar, Joshua D. Grab, Jennifer L. Dodge, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 516-522
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Non-alcoholic fatty liver disease: A patient guideline
Sven Francque, Giulio Marchesini, Achim Kautz, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100322-100322
Open Access | Times Cited: 205
Geographical similarity and differences in the burden and genetic predisposition of NAFLD
Terry Cheuk‐Fung Yip, Eduardo Vilar‐Gómez, Salvatore Petta, et al.
Hepatology (2022) Vol. 77, Iss. 4, pp. 1404-1427
Closed Access | Times Cited: 76
EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy
Catherine Williamson, Melanie Nana, Liona C. Poon, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 768-828
Closed Access | Times Cited: 42
WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification
Giovanna Ferraioli, R. Graham Barr, Annalisa Berzigotti, et al.
Ultrasound in Medicine & Biology (2024) Vol. 50, Iss. 8, pp. 1088-1098
Open Access | Times Cited: 31
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 454-499
Open Access | Times Cited: 30
Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases
Monika Sarkar, Carla W. Brady, Jaquelyn Fleckenstein, et al.
Hepatology (2020) Vol. 73, Iss. 1, pp. 318-365
Open Access | Times Cited: 97
Genetics, epigenetics and transgenerational transmission of obesity in children
Nadia Panera, Claudia Mandato, Annalisa Crudele, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 38
Management of metabolic-associated fatty liver disease: The diabetology perspective
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 126-143
Open Access | Times Cited: 33
Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem
Sébastien Le Garf, Véronique Nègre, Rodolphe Anty, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1915-1915
Open Access | Times Cited: 35
Maternal gestational hypertension, smoking and pre‐eclampsia are associated with metabolic dysfunction‐associated fatty liver disease in overweight offspring
Hanna de Ruyter, Linnea Aitokari, Siiri Lahti, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2024) Vol. 103, Iss. 6, pp. 1183-1191
Open Access | Times Cited: 5
Prepregnancy body mass index and other risk factors for early-onset and late-onset haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome: a population-based retrospective cohort study in British Columbia, Canada
Li Qing Wang, Jeffrey N. Bone, Giulia M. Muraca, et al.
BMJ Open (2024) Vol. 14, Iss. 3, pp. e079131-e079131
Open Access | Times Cited: 5
Experimental model of non-alcoholic fatty liver disease in pregnant rats to evaluate the effectiveness of therapy
Elena V. Mozgovaya, Marina A. Kryshnia, Aleksandra A. Blazhenko, et al.
Journal of obstetrics and women s diseases (2025) Vol. 73, Iss. 6, pp. 116-127
Closed Access
Association between the atherogenic index of plasma and non-alcoholic fatty liver disease in Korean pregnant women: secondary analysis of a prospective cohort study
Rong Shuai, Yuxing He, Dawei Yang, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Pregnancy and the liver
Mussarat N. Rahim, Catherine Williamson, Nikos A. Kametas, et al.
The Lancet (2025) Vol. 405, Iss. 10477, pp. 498-513
Closed Access
Uncoupling protein 1 deficiency leads to transcriptomic differences in livers of pregnancy female mice and aggravates hepatic steatosis
Gang Wei, Feng-Jie Shen, Junli Liu, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110395-110395
Closed Access
A narrative review of metformin in pregnancy: Navigating benefit and uncertainty
Robert C. McEvoy, Christine Newman, Aoife M. Egan, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD)
Elke Roeb
Visceral Medicine (2021) Vol. 37, Iss. 4, pp. 273-280
Open Access | Times Cited: 29
Pathobiology of Metabolic-Associated Fatty Liver Disease
Sherouk Fouda, Mohammed Sadiq Jeeyavudeen, Joseph M. Pappachan, et al.
Endocrinology and Metabolism Clinics of North America (2023) Vol. 52, Iss. 3, pp. 405-416
Closed Access | Times Cited: 12
Association between maternal exposure to per- and polyfluoroalkyl substances and serum markers of liver function during pregnancy in China: A mixture-based approach
Qian Liao, Peng Tang, Haoran Fan, et al.
Environmental Pollution (2023) Vol. 323, pp. 121348-121348
Closed Access | Times Cited: 11
Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals
Tatyana Kushner, Marcia Lange, Pamela Argiriadi, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 1, pp. 194-196.e1
Open Access | Times Cited: 9
Metabolic dysfunction–associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes
Georgia Sofia Karachaliou, Ayako Suzuki
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Liver diseases in pregnancy
Elvyna Lim, Maria Mouyis, Lucy Mackillop
Clinical Medicine (2021) Vol. 21, Iss. 5, pp. e441-e445
Open Access | Times Cited: 22
Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
Hydar El Jamaly, Guy D. Eslick, Martin Weltman
Clinical and Molecular Hepatology (2021) Vol. 28, Iss. 1, pp. 52-66
Open Access | Times Cited: 21
Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
Iresha Sandamali Koralegedara, Janith Warnasekara, Korale Gedara Dayaratne, et al.
BMJ Open Gastroenterology (2022) Vol. 9, Iss. 1, pp. e000831-e000831
Open Access | Times Cited: 15
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update
Sherouk Fouda, Madhu Vennikandam, Joseph M. Pappachan, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 5, pp. 947-954
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top